Medicine Description diabeto-2 2mg
Diabeto 2 is a medication that combines glimepiride and pioglitazone to enhance glycemic control in adults with type 2 diabetes. Glimepiride stimulates the beta cells in the pancreas, promoting the secretion of insulin in response to elevated blood glucose levels. It reduces hepatic glucose output and increases peripheral glucose utilization. On the other hand, pioglitazone works by activating peroxisome proliferator-activated receptors (PPAR-gamma), which play a critical role in glucose and lipid metabolism. This activation enhances insulin sensitivity in muscle and adipose tissues, leading to improved glucose uptake and reduced insulin resistance. Together, these components synergistically aid in better managing blood sugar levels.
Indications and Uses of Diabeto 2
- Management of type 2 diabetes mellitus in conjunction with diet and exercise.
- Used in patients who have not achieved adequate glycemic control with other antidiabetic medications.
Side Effects of Diabeto 2
- Hypoglycemia (low blood sugar levels).
- Weight gain.
- Fluid retention, potentially leading to heart failure.
- Gastrointestinal disturbances such as nausea and diarrhea.
- Elevated liver enzymes.
- Possible risk of bladder cancer with prolonged use of pioglitazone.
Storage and Handling
Store Diabeto 2 at room temperature, away from moisture and heat. Keep it in its original container tightly closed. Protect from light and ensure it is out of reach of children.
Patient Advice and Precautions
Patients should be advised to monitor their blood sugar levels regularly and be aware of the symptoms of hypoglycemia. It is important to maintain a balanced diet and engage in regular physical activity. Pregnant or breastfeeding women should consult their healthcare provider before use. Regular follow-up appointments are essential to assess treatment efficacy and adjust therapy as needed.